Conclusions RTX combining with prednisone was comparable in inducing remission for refractory FSGS patients and was associated with a significantly lower relapse rate and a strong trend towards prolonged relapse-free survival than conventional therapy.
← all excerpts
Efficacy of CD19-guided B-cell depletion with rituximab plus steroids in refractory focal segmental glomerulosclerosis.
1
—
—